Arca
Skip to content
Tools
Tools

PM2™ System with ECGuide™ Connector

Catheter, Intravascular, Therapeutic, Long-Term Greater Than 30 Days. 510(k) K252792, from Piccolo Medical, Inc. (San Francisco, CA). Product code LJS, class 2.

As of Nov 18, 2026, K252792 is an FDA 510(k) held by Piccolo Medical, Inc., substantially equivalent on Nov 17, 2025 after 76 days, with no recalls tied to it in FDA's recall database.

  • Substantially equivalent: Nov 17, 2025
  • Review time: 76 days
  • Recalls: 0

Indications for Use

As the 510(k) summary states them, read from FDA's summary PDF

The PM2™ System with ECGuide™ Connector is indicated for the positioning of central venous access devices (CVADs) of at least 1Fr in size. It provides catheter tip location information by using the patient's cardiac electrical activity.

Predicate Devices

The legally marketed devices this 510(k) summary says it is substantially equivalent to, read from FDA's summary PDF

Other LJS Clearances

The newest 510(k)s for the same product code; their median review was 202 days; see every LJS device

Record

Type
Special
Received
Sep 2, 2025
Review panel
General Hospital
Regulation
21 CFR 880.5970

One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files

Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.